Herein, we identified 6 factors, including hepatic metastases, tumor size, AC of CD3+, CD4+, CD8+, and B cells, were correlated with the efficacy of anti-PD-1 inhibitors and PFS in training cohort. Here, CD4 is linked to neoplasm.